Microbiome and Gut Health
The human microbiome, composed of trillions of bacteria, fungi, viruses, and other microorganisms, plays a crucial role in maintaining overall health, including liver function. The gut-liver axis refers to the bidirectional communication between the gastrointestinal (GI) tract and the liver. The microbiome influences liver health through various mechanisms, including immune modulation, metabolism, and the detoxification process.
- Gut Microbiome and Liver Disease: An imbalance in the gut microbiome, known as dysbiosis, has been linked to several liver diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), cirrhosis, and liver cancer (HCC). Dysbiosis can lead to increased intestinal permeability ("leaky gut"), allowing harmful substances, such as endotoxins, to enter the bloodstream.
- Microbiome in NAFLD and NASH: In the context of NAFLD and NASH, gut microbiota imbalances contribute to the accumulation of fat in the liver, insulin resistance, and inflammatory responses that aggravate liver injury. Studies suggest that microbiome therapies, such as probiotics, prebiotics, and dietary interventions, may improve liver function by restoring microbial balance and reducing inflammation.
- Liver Detoxification and Metabolism: The gut microbiome also affects the liver's role in detoxifying harmful substances. Certain gut bacteria produce short-chain fatty acids (SCFAs) like butyrate, which help maintain gut barrier function and regulate the liver's metabolic processes. The gut microbiota also influences the liver’s ability to metabolize drugs, alcohol, and other toxic substances, making it a key player in detoxification.
Related Conference of Microbiome and Gut Health
January 25-26, 2027
26th International Conference on Gastroenterology and Hepatology
Edinburgh, Scotland
Microbiome and Gut Health Conference Speakers
Recommended Sessions
- Advanced Liver Regeneration and Stem Cell Research
- Advanced Techniques in Gastrointestinal Imaging
- Advancements in Non-invasive Liver Diagnostic
- Advances in Endoscopic Techniques and Innovations
- Advances in Gut-Associated Lymphoid Tissue (GALT) and Immunity
- Advances in Pancreatitis Treatment: Managing Acute and Chronic Cases
- AI in Early Diagnosis of Colorectal Cancer
- Chronic liver disease management
- Colorectal Cancer: Early Detection, Diagnosis, and Therapeutics
- CRISPR-Cas9 in Gastrointestinal and Hepatic Disease Research
- Genetic and Immunological Mechanisms in Autoimmune Gastrointestinal Disorders
- Genetic Markers for Predicting Inflammatory Responses in Liver Disease
- Genetic Pathways in Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH
- Gut-Brain Connection in Gastroenterology
- Hepatitis D: The Silent Epidemic in Hepatology
- Hepatitis E: Latest Updates and Research
- Hepatocellular Carcinoma (HCC): Early Detection and Management
- Immunology and Genetic Mechanisms in Liver Transplantation
- Immunotherapy in GI Cancer Treatment
- Microbiome and Gut Health
- Microbiome and Its Impact on Colorectal Cancer (CRC)
- Obesity and Bariatric Surgery
- Pediatric Gastroenterology and Hepatology
- Precision medicine in gastroenterology
- Role of Artificial Intelligence in Clinical Decision Making
- Role of MicroRNAs in Genetic Regulation of Liver Diseases
- Targeting Genetic Pathways in Gastrointestinal Inflammation
- Translational Research in Gastroenterology and Hepatology
Related Journals
Are you interested in
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Celiac Disease - Gastrosummit 2027 (France)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Viral Hepatitis - Gastrosummit 2027 (France)

